These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1370183)

  • 1. G-CSF for fever and neutropenia induced by chemotherapy.
    Auchter RM
    N Engl J Med; 1992 Jan; 326(4):269-70. PubMed ID: 1370183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytokines in cancer chemotherapy: present state and problems in use of G- and GM-CSF for solid tumors in Japan].
    Ogawara M
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):164-70. PubMed ID: 9474924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF for fever and neutropenia induced by chemotherapy.
    Hamm JT
    N Engl J Med; 1992 Jan; 326(4):269; author reply 270. PubMed ID: 1370180
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells.
    Humblet Y; Bosquée L; Weynants P; Symann M
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S36-9. PubMed ID: 8899169
    [No Abstract]   [Full Text] [Related]  

  • 6. The frequency and management of infectious episodes and sepsis in small cell lung cancer patients receiving intensive chemotherapy with granulocyte-colony stimulating factor.
    Oshita F; Tamura T; Okamoto H; Miya T; Kojima A; Ohe Y; Sasaki Y; Eguchi K; Shinkai T; Saijo N
    Jpn J Clin Oncol; 1991 Oct; 21(5):353-9. PubMed ID: 1721656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF reduces incidence of chemotherapy-associated infections.
    Oncology (Williston Park); 1990 Aug; 4(8):12. PubMed ID: 1698430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Small cell lung cancer: value of G-CSF].
    Trillet V
    Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose intensity in small cell lung cancer.
    Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF for fever and neutropenia induced by chemotherapy.
    Higa GM
    N Engl J Med; 1992 Jan; 326(4):269; author reply 270. PubMed ID: 1370181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Debate on the treatment of small cell cancers. Utilization of hematopoietic growth factors: necessity for a new trial].
    Lebeau B
    Rev Mal Respir; 1996; 13(1):84. PubMed ID: 8650427
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of psoriasis by human recombinant granulocyte colony stimulating factor in a patient with small cell lung cancer].
    Yonei T; Watanabe K; Sato T; Yamadori I
    Nihon Kokyuki Gakkai Zasshi; 2001 Jun; 39(6):438-41. PubMed ID: 11530395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer.
    Riikonen P; Rahiala J; Salonvaara M; Perkkiö M
    Stem Cells; 1995 May; 13(3):289-94. PubMed ID: 7542114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
    Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
    Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.